DNB Asset Management AS Sells 18,380 Shares of CME Group Inc. $CME

DNB Asset Management AS lowered its holdings in shares of CME Group Inc. (NASDAQ:CME) by 19.5% in the 3rd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 75,958 shares of the financial services provider’s stock after selling 18,380 shares during the quarter. DNB Asset Management AS’s holdings in CME Group were worth $20,523,000 as of its most recent filing with the Securities & Exchange Commission.

Several other institutional investors have also recently made changes to their positions in CME. Jessup Wealth Management Inc lifted its position in CME Group by 0.5% during the second quarter. Jessup Wealth Management Inc now owns 7,969 shares of the financial services provider’s stock valued at $2,197,000 after purchasing an additional 36 shares in the last quarter. First Horizon Advisors Inc. increased its position in CME Group by 0.7% in the second quarter. First Horizon Advisors Inc. now owns 5,269 shares of the financial services provider’s stock worth $1,453,000 after buying an additional 36 shares in the last quarter. MBM Wealth Consultants LLC raised its stake in shares of CME Group by 2.7% in the second quarter. MBM Wealth Consultants LLC now owns 1,422 shares of the financial services provider’s stock worth $392,000 after buying an additional 37 shares during the period. West Family Investments Inc. lifted its position in shares of CME Group by 1.2% during the 3rd quarter. West Family Investments Inc. now owns 3,062 shares of the financial services provider’s stock valued at $827,000 after buying an additional 37 shares in the last quarter. Finally, Atlatl Advisers LLC increased its holdings in CME Group by 1.8% in the 3rd quarter. Atlatl Advisers LLC now owns 2,126 shares of the financial services provider’s stock worth $574,000 after acquiring an additional 38 shares in the last quarter. Institutional investors own 87.75% of the company’s stock.

Analyst Ratings Changes

A number of research firms have weighed in on CME. The Goldman Sachs Group upped their price target on shares of CME Group from $264.00 to $266.00 and gave the stock a “sell” rating in a research report on Monday, February 9th. Argus dropped their target price on shares of CME Group from $308.00 to $295.00 in a report on Friday, October 31st. Royal Bank Of Canada raised their price target on CME Group from $295.00 to $302.00 and gave the company a “sector perform” rating in a report on Thursday, February 5th. Morgan Stanley boosted their price objective on CME Group from $319.00 to $340.00 and gave the company an “overweight” rating in a research report on Thursday, February 5th. Finally, Bank of America increased their target price on CME Group from $201.00 to $209.00 in a research report on Wednesday, December 10th. Nine equities research analysts have rated the stock with a Buy rating, six have issued a Hold rating and three have given a Sell rating to the company’s stock. Based on data from MarketBeat.com, CME Group currently has a consensus rating of “Hold” and a consensus target price of $299.53.

CME Group Trading Up 1.0%

Shares of CME stock opened at $319.50 on Friday. The company has a market cap of $115.21 billion, a PE ratio of 28.63, a price-to-earnings-growth ratio of 3.70 and a beta of 0.27. CME Group Inc. has a 1 year low of $248.53 and a 1 year high of $322.57. The stock’s 50 day simple moving average is $287.63 and its two-hundred day simple moving average is $275.97. The company has a debt-to-equity ratio of 0.12, a current ratio of 1.03 and a quick ratio of 1.02.

CME Group (NASDAQ:CME) last issued its quarterly earnings results on Wednesday, February 4th. The financial services provider reported $2.77 EPS for the quarter, beating the consensus estimate of $2.75 by $0.02. CME Group had a net margin of 62.45% and a return on equity of 14.65%. The company had revenue of $1.65 billion for the quarter, compared to the consensus estimate of $1.64 billion. During the same period in the prior year, the firm posted $2.52 EPS. The firm’s revenue was up 8.1% compared to the same quarter last year. Research analysts predict that CME Group Inc. will post 10.49 earnings per share for the current year.

CME Group Increases Dividend

The company also recently declared a quarterly dividend, which will be paid on Thursday, March 26th. Stockholders of record on Tuesday, March 10th will be given a dividend of $1.30 per share. This represents a $5.20 dividend on an annualized basis and a dividend yield of 1.6%. The ex-dividend date of this dividend is Tuesday, March 10th. This is a positive change from CME Group’s previous quarterly dividend of $1.25. CME Group’s dividend payout ratio is currently 44.80%.

Insider Activity

In other news, Director Bryan T. Durkin sold 4,200 shares of the business’s stock in a transaction on Monday, February 23rd. The stock was sold at an average price of $309.65, for a total value of $1,300,530.00. Following the completion of the transaction, the director directly owned 43,007 shares of the company’s stock, valued at approximately $13,317,117.55. The trade was a 8.90% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Also, Director William R. Shepard purchased 251 shares of the firm’s stock in a transaction on Tuesday, December 30th. The shares were purchased at an average cost of $278.37 per share, with a total value of $69,870.87. Following the completion of the transaction, the director owned 258,710 shares of the company’s stock, valued at approximately $72,017,102.70. The trade was a 0.10% increase in their position. The SEC filing for this purchase provides additional information. In the last 90 days, insiders have sold 30,248 shares of company stock valued at $8,355,450. Company insiders own 0.30% of the company’s stock.

Key Stories Impacting CME Group

Here are the key news stories impacting CME Group this week:

• Positive Sentiment: CME reported record 2025 results: $6.5B in revenue, AD volume rose 6% to 28.1M contracts (commodities +12%, financials +5%), highlighting continued franchise growth and fee-related revenue strength. This earnings strength is the primary bullish catalyst. CME Group (CME) Achieves Record 2025 Results with $6.5B in Revenue
• Positive Sentiment: CME expanded physical-market infrastructure by approving the first aluminium warehousing facility in Taiwan, supporting commodities product growth and global market access for metals. That strengthens long-term fees and product diversification. CME approves first aluminium warehousing in Taiwan
• Neutral Sentiment: Intraday data and flow reports show mixed signals: QuiverQuant flagged heavy volume and both insider selling and sizable institutional position changes (some managers added, some trimmed). This suggests active rebalancing rather than a clear directional bet. $CME stock is up 2% today. Here’s what we see in our data.
• Neutral Sentiment: Reported short-interest data in the feed appears anomalous (zeros/NaN). No clear short-pressure signal is evident from that entry, so it shouldn’t be driving meaningful price moves. (Treat as data glitch/unreliable.)
• Negative Sentiment: CME experienced a brief technical glitch that halted metals and natural gas trading on Globex and briefly pressured the stock when markets reacted; trading was subsequently restarted. Operational reliability concerns can weigh on near-term sentiment until fully resolved. CME Group halts metals and natural gas trading on technical issues
• Negative Sentiment: Commentary criticizing CME’s Variable Storage Rate program (commodity storage economics) may pressure sentiment among some commodities market participants; impact is likely niche but could attract headlines. Why I Hate Variable Storage Rates

CME Group Company Profile

CME Group Inc is a global markets company that operates some of the world’s largest and most liquid derivatives exchanges, including the Chicago Mercantile Exchange (CME), the Chicago Board of Trade (CBOT), the New York Mercantile Exchange (NYMEX) and COMEX. The firm offers futures and options contracts across a broad range of asset classes — including interest rates, equity indexes, foreign exchange, energy, agricultural commodities and metals — and serves a diverse client base of institutional investors, commercial hedgers, brokers and retail participants.

The company’s core services include electronic trading on the CME Globex platform, central clearing through CME Clearing, and distribution of market data, indexes and analytics.